This content is machine translated Atopic dermatitis Implement the “minimal disease activity” concept Minimal disease activity (MDA) in atopic dermatitis (AD) is a concept that combines a treat-to-target therapeutic strategy with the principle of shared decision-making. The aim is to achieve a state...…
View Post 8 min This content is machine translated Chronic inducible urticaria What has stayed the same, what has changed? Over the past decades, significant progress has been made in understanding the pathogenesis of chronic inducible urticaria (CIndU). Provocation tests continue to play an important role in confirming the diagnosis....…
View Post 8 min This content is machine translated Psoriasis and PsA Biologics, oral peptide and trivalent nanobody – current results and trends Top-line results are available for both Icotrokinra and Sonelokimab, which attest to the great therapeutic potential of these innovative drug candidates. However, there is also extremely interesting new evidence from...…
View Post 6 min This content is machine translated Biologics for plaque psoriasis What increases the chance of a sustained remission? State-of-the-art technologies now make it possible to decipher the aetiopathogenesis of skin diseases at a molecular level, which can be used to optimize treatment strategies. In plaque psoriasis – a...…
View Post 7 min This content is machine translated Journal Club Management of axial spondyloarthritis In patients with axial spondyloarthritis (axSpA), chronic back pain typically manifests itself for the first time before the age of 45. Timely referral to rheumatology specialists and close monitoring of...…
View Post 4 min This content is machine translated Biologics for atopic dermatitis Th2 cytokines in focus: proven and new targets The range of antibody therapies for atopic dermatitis (AD) has expanded once again in Europe. In addition to dupilumab and tralokinumab, lebrikizumab is another biologic available in this country that...…
View Post 2 min This content is machine translated CFTR modulators and biologics More attention for neurocognitive side effects CFTR modulators and biologics have had a significant impact on the treatment of cystic fibrosis and severe asthma in recent years. Despite all the benefits that these active substances bring,...…
View Post 8 min This content is machine translated Psoriasis treatment with biologics What are the latest trends? Novel oral therapies are currently being researched – promising data from clinical trials is now available. In the field of approved, subcutaneously administered IL-23 and IL-17 antagonists, current real-world data...…
View Post 8 min This content is machine translated Hidradenitis suppurativa/acne inversa Relieving suffering and inflammation – how can this be achieved? Quite a few patients affected by hidradenitis suppurativa/acne inversa suffer from disease manifestations long before targeted therapeutic measures are taken. There are various reasons for this. One approach to tackling...…
View Post 5 min This content is machine translated SDNTT register data Psychological comorbidities in psoriasis Inflammatory systemic diseases such as psoriasis are associated with a high risk of comorbidity. In addition to cardiometabolic diseases, mental disorders are particularly common in this patient population. As part…
View Post 5 min This content is machine translated Journal Club GPP flares: new real-world data published Relapses characterized by large pustules on the skin are characteristic of generalized pustular psoriasis (GPP) and can be associated with systemic inflammatory reactions and serious complications. A study published this…
